Loading clinical trials...
Loading clinical trials...
Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Patients Who Are Non-responders to Interferon Alpha Plus Ribavirin
Conditions
Interventions
interferon alpha-2b, ribavirin, interferon-gamma,
interferon alpha-2b, ribavirin, amantadine
Locations
2
Pakistan
Medicare Clinic
Karachi, Pakistan
The Aga Khan University Hospital
Karachi, Pakistan
Last Updated
October 27, 2010
NCT06953479
NCT03135886
NCT05968573
NCT05042544
NCT05870969
NCT05361603
Lead Sponsor
Aga Khan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions